» Articles » PMID: 21586936

Is There a Role for Fluorine 18 Fluorodeoxyglucose-positron Emission Tomography and Positron Emission Tomography/computed Tomography in Evaluating Patients with Mycobacteriosis? A Systematic Review

Overview
Specialty Radiology
Date 2011 May 19
PMID 21586936
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study was designed to review the emerging role of fluorine 18 fluorodeoxyglucose (¹⁸F-FDG)-positron emission tomography (PET) CT/computed tomography (PET/CT) in patients with mycobacteriosis.

Methods: A comprehensive literature search of published studies through October 2010 in PubMed/MEDLINE database regarding ¹⁸F-FDG-PET and PET/CT in patients with mycobacteriosis was performed.

Results: Ultimately, we identified 16 studies comprising a total of 220 patients with mycobacteriosis. Main findings of the included studies are presented.

Conclusions: (1) Mycobacteriosis commonly causes increased ¹⁸F-FDG uptake; therefore, positive ¹⁸F-FDG-PET results should be interpreted with caution in differentiating benign from malignant abnormalities. (2) ¹⁸F-FDG-PET and PET/CT are potentially useful in detecting sites of Mycobacterium infection. (3) Dual-phase ¹⁸F-FDG-PET is not useful for the differential diagnosis between malignant lesions and sites of Mycobacterium infection. (4) ¹⁸F-FDG-PET and PET/CT are useful for the evaluation of disease activity and in monitoring response to therapy in patients with mycobacteriosis. (5) Dual-tracer PET and PET/CT are potentially useful for presumptive diagnosis of solitary pulmonary nodules.

Citing Articles

The Effect of Hounsfield Unit Value on the Differentiation of Malignant/Benign Mediastinal Lymphadenopathy and Masses Diagnosed by Endobronchial Ultrasonography.

Gegin S, Pazarli A, Ozdemir B, Ozdemir L, Aksu E Cancer Manag Res. 2024; 16:1013-1020.

PMID: 39157714 PMC: 11330239. DOI: 10.2147/CMAR.S473653.


Simultaneous 18F-FDG PET/MRI in tuberculous spondylitis: an independent method for assessing therapeutic response - case series.

Jeon I, Kong E, Kim S BMC Infect Dis. 2019; 19(1):845.

PMID: 31615426 PMC: 6794893. DOI: 10.1186/s12879-019-4469-2.


Diagnostic Performance of F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses.

Treglia G Contrast Media Mol Imaging. 2019; 2019:3018349.

PMID: 31427907 PMC: 6683817. DOI: 10.1155/2019/3018349.


F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation.

Muller N, Kessler R, Caillard S, Epailly E, Hubele F, Heimburger C Nucl Med Mol Imaging. 2017; 51(1):58-68.

PMID: 28250859 PMC: 5313469. DOI: 10.1007/s13139-016-0461-6.


The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.

Sun Y, Yu H, Ma J, Lu P PLoS One. 2016; 11(8):e0161764.

PMID: 27560933 PMC: 4999143. DOI: 10.1371/journal.pone.0161764.